4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-20-018224
President and CEO acquired 191,952 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Domzalski David · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-09 | Grant or award : show line 1 in the form | +53,850 | 53,850 | D |
| 2020-03-09 | Grant or award : show line 2 in the form | +138,102 | 191,952 | D |
Table II: Derivative
8 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-03-09 | Grant or award : show line 3 in the form Stock Options | +11,107 | $13.48 | 2024-06-09 | 11,107 | 11,107 | D |
| 2020-03-09 | Grant or award : show line 4 in the form Stock Options | +140,286 | $12.06 | 2025-11-10 | 140,286 | 140,286 | D |
| 2020-03-09 | Grant or award : show line 5 in the form Stock Options | +35,544 | $10.20 | 2026-03-01 | 35,544 | 35,544 | D |
| 2020-03-09 | Grant or award : show line 6 in the form Stock Options | +42,278 | $17.25 | 2027-01-01 | 42,278 | 42,278 | D |
| 2020-03-09 | Grant or award : show line 7 in the form Stock Options | +194,141 | $9.73 | 2027-08-08 | 194,141 | 194,141 | D |
| 2020-03-09 | Grant or award : show line 8 in the form Stock Options | +41,578 | $8.55 | 2028-02-27 | 41,578 | 41,578 | D |
| 2020-03-09 | Grant or award : show line 9 in the form Stock Options | +101,296 | $6.37 | 2029-01-01 | 101,296 | 101,296 | D |
| 2020-03-09 | Grant or award : show line 10 in the form Stock Options | +142,716 | $6.81 | 2030-02-24 | 142,716 | 142,716 | D |
Loading xslF345X03/doc4.xml…